Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma

IMPORTANCE: Several immune checkpoint inhibitors (ICIs) are approved for use in patients with metastatic renal cell carcinoma (mRCC), but the efficacy and safety of ICI rechallenge in mRCC is unknown. OBJECTIVE: To evaluate the safety and efficacy of ICI rechallenge in patients with mRCC. DESIGN, SE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Ravi, Praful, Mantia, Charlene, Su, Christopher, Sorenson, Karl, Elhag, Dean, Rathi, Nityam, Bakouny, Ziad, Agarwal, Neeraj, Zakharia, Yousef, Costello, Brian A., McKay, Rana R., Narayan, Vivek, Alva, Ajjai, McGregor, Bradley A., Gao, Xin, McDermott, David F., Choueiri, Toni K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7260689/
https://ncbi.nlm.nih.gov/pubmed/32469396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.2169
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados